Represented Amneal in Litigation Over ADHD Medication

July 26, 2017

Janssen/Alza v. Amneal Pharms. LLC

Robins Kaplan LLP served as counsel for Amneal in Hatch-Waxman patent litigation in the District of Delaware involving a number of patents related to ADHD medication Concerta (methylphenidate). The parties stipulated to dismissal on July 26, 2017.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer
Back to Top